Evidence map›Paper›PMID 1332696›Full record

ArticleThe Biochemical journal1992

Regulation of platelet-activating-factor receptors and the desensitization response in polymorphonuclear neutrophils.

J T O'Flaherty, D P Jacobson, J F Redman

Open access · bronzeAbstract read
In one paragraph

Article in The Biochemical journal, 1992. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Platelet-activating factor antagonists.Clinical reviews in allergy · 1994
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

J T O'FlahertyDepartment of Medicine, Wake Forest University Medical Center, Winston-Salem, NC 27157-1042.
D P Jacobson
J F Redman
Atrium Health Wake Forest Baptist · US

Funding

ARACHIDONIC ACID AND NEUTROPHIL FUNCTIONR01HL026257 · NHLBI · WAKE FOREST UNIVERSITY · PI O'FLAHERTY, JOSEPH T. · 1985 to 1996
–
GLYCEROLIPIDS, THEIR DERIVATIVES, AND NEUTROPHILSR01HL027799 · NHLBI · WAKE FOREST UNIVERSITY · PI O'FLAHERTY, JOSEPH T. · 1985 to 1993
–
NHLBI NIH HHS HL-26257NHLBI NIH HHS HL-27799
6 · The paper itself

Abstract

Platelet-activating factor (PAF) desensitizes as well as stimulates its various target cells, We find that human polymorphonuclear neutrophils (PMN) exposed to PAF became maximally unresponsive to a second PAF challenge within 15-90 s in assays of Ca2+ mobilization and degranulation. The cells regained full PAF-sensitivity over the ensuing 20-40 min. These effects correlated with changes in PAF receptor availability. PMN treated with PAF, washed in regular buffer and assayed for PAF binding exhibited falls (maximal in 15 s), followed by rises (reaching control levels by 60 min), in the number of high-affinity PAF receptors. However, tracking studies showed that [3H]PAF accumulated on the cell surface for approximately 2 min before being internalized. Regular-buffer washes did not remove this superficial PAF, whereas a washing regimen using excess albumin to adsorb PAF removed 99% of the surface compound. PMN washed by the latter regimen after PAF exposure lost PAF receptors relatively slowly (maximal at approximately 5 min), but the ultimate extent of this loss and the rate at which receptor expression normalized were similar to those of cells washed in regular buffer. Neither cycloheximide nor actinomycin D influenced the course of the receptor changes, but two protein kinase C (PKC) blockers, staurosporine and 1-(5-isoquinolinesulphonyl)piperazine, inhibited the receptor-receptor-depleting actions of PAF. Indeed, a phorbol diester activator of PKC also caused PMN to decrease high-affinity PAF receptor numbers, and the two PKC blockers antagonized this action at concentrations that inhibited PAF-induced PAF receptor losses. We conclude that: (a) PAF induces PMN to down-regulate and then to re-express PAF receptors independently of protein synthesis; (b) these changes are likely to underlie the later stages and reversal of desensitization; (c) the onset (t < or = 2 min) of desensitization, however, precedes receptor down-regulation and must be due to receptor uncoupling from transductional elements; and (d) down-regulation of receptors for PAF appears to be mediated by PKC and/or elements inhibited by PKC blockers.

Indexed as

Platelet Membrane GlycoproteinsReceptors, G-Protein-CoupledCalciumCycloheximideDactinomycinHumansKineticsNeutrophilsN-Formylmethionine Leucyl-PhenylalaninePlatelet Activating FactorReceptors, Cell SurfaceSerum Albumin, BovineCalciumCycloheximideDactinomycinN-Formylmethionine Leucyl-PhenylalaninePlatelet Activating Factorplatelet activating factor receptorPlatelet Membrane GlycoproteinsReceptors, Cell SurfaceReceptors, G-Protein-CoupledSerum Albumin, Bovine

Identifiers

PMID1332696
PMCPMC1132104
OpenAlexW2338194453

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.